These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting. Le NT; Chen BJ; Chao NJ Cytotherapy; 2005; 7(2):126-33. PubMed ID: 16040391 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic reconstitution after nonmyeloablative conditioning: mitigation of graft-versus-host and host-versus-graft reactivity by anti-CD44v6. Christ O; Günthert U; Schmidt DS; Zöller M J Leukoc Biol; 2002 Jan; 71(1):33-46. PubMed ID: 11781378 [TBL] [Abstract][Full Text] [Related]
6. Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool. Fukunaga A; Ishikawa T; Kishihata M; Shindo T; Hori T; Uchiyama T Biol Blood Marrow Transplant; 2007 Oct; 13(10):1176-84. PubMed ID: 17889354 [TBL] [Abstract][Full Text] [Related]
7. The thymus in GVHD pathophysiology. Krenger W; Holländer GA Best Pract Res Clin Haematol; 2008 Jun; 21(2):119-28. PubMed ID: 18503980 [TBL] [Abstract][Full Text] [Related]
8. Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer. Schirrmacher V; Beckhove P; Choi C; Griesbach A; Mahnke Y Int J Oncol; 2005 Oct; 27(4):1141-9. PubMed ID: 16142333 [TBL] [Abstract][Full Text] [Related]
9. Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras. de Jager SC; Canté-Barrett K; Bot I; Husberg C; van Puijvelde GH; van Santbrink PJ; Yndestad A; van den Oever JM; Kuiper J; van Berkel TJ; Lipp M; Zwaginga JJ; Fibbe WE; Aukrust P; Biessen EA Transplantation; 2009 Sep; 88(5):631-9. PubMed ID: 19741459 [TBL] [Abstract][Full Text] [Related]
14. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects. Ratanatharathorn V; Pavletic S; Uberti JP Cancer Treat Rev; 2009 Dec; 35(8):653-61. PubMed ID: 19682801 [TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A light. Mabed M; Coffe C; Racadot E; Angonin R; Pavey JJ; Tiberghien P; Herve P Ann Hematol; 2006 Jan; 85(1):17-24. PubMed ID: 16208471 [TBL] [Abstract][Full Text] [Related]
16. Cytolytic pathways used by effector cells derived from recipient naive and memory T cells and natural killer cells in resistance to allogeneic hematopoietic cell transplantation. Zimmerman Z; Jones M; Shatry A; Komatsu M; Mammolenti M; Levy R Biol Blood Marrow Transplant; 2005 Dec; 11(12):957-71. PubMed ID: 16338617 [No Abstract] [Full Text] [Related]
17. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation. Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138 [TBL] [Abstract][Full Text] [Related]
18. Induction of tolerance in organ recipients by hematopoietic stem cell transplantation. Ophir E; Reisner Y Int Immunopharmacol; 2009 Jun; 9(6):694-700. PubMed ID: 19150657 [TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanisms in graft-versus-host responses. Edinger M; Powrie F; Chakraverty R Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):2-6. PubMed ID: 19147068 [TBL] [Abstract][Full Text] [Related]
20. A role for mesenchymal stem cells in the control of graft-versus-host disease. Cohen JL; Sudres M Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]